# PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer

> **NCT02042053** · NA · TERMINATED · sponsor: **NYU Langone Health** · enrollment: 10 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DEVICE:** PET/CT
- **DEVICE:** PET/MRI

## Key facts

- **NCT ID:** NCT02042053
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-01
- **Primary completion:** 2015-05
- **Final completion:** 2015-10
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Due to PI leaving the institution
- **Last updated:** 2017-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02042053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02042053, "PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02042053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*